2010
DOI: 10.1016/j.jcv.2010.04.007
|View full text |Cite
|
Sign up to set email alerts
|

Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
57
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 73 publications
(58 citation statements)
references
References 45 publications
(70 reference statements)
1
57
0
Order By: Relevance
“…Genus-specific, real-time PCR-positive specimens were confirmed by nested or seminested RT-PCR targeting a portion of the genome region encoding the VP1 capsid protein, followed by amplicon sequencing (8,12). Virus type identity was determined by comparison of the VP1 amplicon nucleotide and deduced amino acid sequences with the VP1 sequences of all the reference strains for each virus genus by script-driven sequential pairwise comparison using the program Gap (Wisconsin Sequence Analysis Package, version 11.0; Accelrys, Inc., San Diego, CA) as described previously (8).…”
Section: Methodsmentioning
confidence: 99%
“…Genus-specific, real-time PCR-positive specimens were confirmed by nested or seminested RT-PCR targeting a portion of the genome region encoding the VP1 capsid protein, followed by amplicon sequencing (8,12). Virus type identity was determined by comparison of the VP1 amplicon nucleotide and deduced amino acid sequences with the VP1 sequences of all the reference strains for each virus genus by script-driven sequential pairwise comparison using the program Gap (Wisconsin Sequence Analysis Package, version 11.0; Accelrys, Inc., San Diego, CA) as described previously (8).…”
Section: Methodsmentioning
confidence: 99%
“…Virus identifications of genus-specific real-time RT-PCR-positive specimens were determined by nested or seminested RT-PCR targeting a portion of the genome region encoding the VP1 capsid protein (Tables 3 and 4), followed by amplicon sequencing (32,36). An additional human PeV (HPeV) partial VP1 assay (does not amplify Ljungan virus species) was used on a small number of specimens that yielded an unreadable sequence with the complete VP1 assay (Tables 3 and 4).…”
Section: Studymentioning
confidence: 99%
“…An additional human PeV (HPeV) partial VP1 assay (does not amplify Ljungan virus species) was used on a small number of specimens that yielded an unreadable sequence with the complete VP1 assay (Tables 3 and 4). The cDNA reactions for these specimens were performed as described previously for the parechovirus complete VP1 assay (36). The PCR1 reaction differed slightly from the previously described parechovirus complete VP1 PCR1 assay in that the HPeV primers (AN486 and AN488) were used at 0.5 M in the final reaction volume of 50 l. Similarly, the HPeV PCR2 primers (AN268 and AN489) were used at 0.4 M in the final reaction volume of 50 l. Thermocycler profiles for the HPeV partial VP1 assay were as described for the EV partial VP1 assay (36).…”
Section: Studymentioning
confidence: 99%
See 1 more Smart Citation
“…To determine the complete VP1 coding sequences, HPeVpositive specimens were amplified using the nested PCR assays described by Nix et al 12 The nucleotide sequences obtained were deposited in the EBI/DDBJ/GenBank databases under the accession numbers JQ229434-JQ229466. These sequences were aligned with those of prototype and clinical strains from GenBank, using the ClustalW program.…”
Section: Hpev Genotypingmentioning
confidence: 99%